E
Calliditas Therapeutics AB (publ) CALT
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2024 03/31/2024 12/31/2023 09/30/2023 06/30/2023
Net Income -4.44M -23.68M -1.73M -15.58M -8.74M
Total Depreciation and Amortization -- -- 1.56M -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.81M 3.30M 4.96M 4.23M -2.05M
Change in Net Operating Assets -3.03M 1.31M -2.64M 5.57M -4.71M
Cash from Operations -658.80K -19.07M 2.15M -5.79M -15.49M
Capital Expenditure -- -- -1.20M -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -9.50K -371.20K 981.30K -686.40K -100.70K
Cash from Investing -9.50K -371.20K -221.40K -686.40K -100.70K
Total Debt Issued -- -- 962.89M -- --
Total Debt Repaid -4.06M -5.47M -727.74M -2.89M -3.02M
Issuance of Common Stock 14.00K -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -26.63M -- --
Cash from Financing -378.40K -526.00K 19.61M -267.30K -286.50K
Foreign Exchange rate Adjustments -172.90K 4.24M -3.97M -598.20K 1.87M
Miscellaneous Cash Flow Adjustments -- -- -100.00 -- -100.00
Net Change in Cash -1.22M -15.72M 17.57M -7.34M -14.01M
Weiss Ratings